Emily M. Leproust, Chief Executive Officer at Twist Bioscience Corp (TWST), sold 16,470 shares at $65.33 ($1.1M) on 2026-05-28, disclosed to the SEC on 2026-06-01.
Scheduled sale ($1.1M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.33 | 1,482 | $97K | 8.7% |
| 2 | $66.85 | 900 | $60K | 5.4% |
| 3 | $67.95 | 7,623 | $518K | 46.3% |
| 4 | $68.61 | 6,465 | $444K | 39.7% |
| Total | $67.91 avg | 16,470 | $1.1M | 100% |
| Filing → |
| TWST | SELL | 2026-09-25 | $923K | — | Filing → |
| TWST | SELL | 2026-09-23 | $279K | — | Filing → |
| TWST | SELL | 2026-09-21 | $56.3M | — | Filing → |